Acquisition / mergerNotableFiled on BSE ·

Entero Healthcare to acquire Vishal Surgicals; reappoints 3 directors; grants 7,300 ESOPs

Entero Healthcare Solutions · Retailing

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Acquisition of Vishal Surgicals and Vishal Surgicals & Medicals via subsidiary Sai Pharma Distributors through slump sale / business transfer agreement.
  • Re-appoints Sujesh Vasudevan, Rajesh Shashikant Dalal and Sandhya Gadkari Sharma as Non-Executive Independent Directors for five years from August 25, 2026, subject to AGM approval.
  • Fresh 7,300 employee stock options granted under Entero Employee Stock Option Plan 2023, noted by the Board.

Why it's rated notable: the year-on-year change is 44% (20% to 50%)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Entero Healthcare Solutions

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.